Jefferies Group LLC Cassava Sciences Inc Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Jefferies Group LLC holds 34,753 shares of SAVA stock, worth $50,739. This represents 0.01% of its overall portfolio holdings.

Number of Shares

34,753

Previous 59,063 41.16%

Holding current value

$50,739

Previous $1.66 Million 12.47%

% of portfolio

0.01%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$16.33 - $51.06 $396,982 - $1.24 Million	-24,310 Reduced 41.16%	34,753 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $396,982 - $1.24 Million	-24,310 Reduced 41.16%	34,753 $1.45 Million
Q2 2022 Sep 21, 2023	BUY	$17.22 - $38.47 $812,749 - $1.82 Million	47,198 Added 397.79%	59,063 $1.66 Million
Q2 2022 Aug 15, 2022	BUY	$17.22 - $38.47 $812,749 - $1.82 Million	47,198 Added 397.79%	59,063 $1.66 Million
Q2 2021 Sep 21, 2023	SELL	$32.15 - $89.72 $36,490 - $101,832	-1,135 Reduced 8.73%	11,865 $1.01 Million
Q2 2021 Aug 16, 2021	SELL	$32.15 - $89.72 $36,490 - $101,832	-1,135 Reduced 8.73%	11,865 $1.01 Million
Q1 2021 Sep 21, 2023	SELL	$7.09 - $87.95 $794,080 - $9.85 Million	-112,000 Reduced 89.6%	13,000 $584,000
Q1 2021 May 14, 2021	SELL	$7.09 - $87.95 $794,080 - $9.85 Million	-112,000 Reduced 89.6%	13,000 $584,000
Q4 2020 Sep 21, 2023	BUY	$6.79 - $12.25 $612,777 - $1.11 Million	90,247 Added 259.68%	125,000 $852,000
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $169,750 - $306,250	25,000 Added 25.0%	125,000 $853,000
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $40,800 - $192,800	20,000 Added 25.0%	100,000 $308,000
Q1 2020 May 15, 2020	BUY	$3.26 - $9.65 $32,599 - $96,500	10,000 Added 14.29%	80,000 $329,000
Q4 2019 Feb 13, 2020	BUY	$1.1 - $6.12 $77,000 - $428,400	70,000 New	70,000 $364,000

Others Institutions Holding SAVA

# of Institutions

188

Shares Held

16.4M

Call Options Held

3.49M

Put Options Held

8.08M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $58.5M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Cassava Sciences Inc Transaction History